Public Alert No. 037/2023 – Alert on Substandard (contaminated) syrup and suspension medicines identified in the WHO Regions of the Americas, Eastern Mediterranean, South-East Asia and Western Pacific
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying Healthcare providers and the general public of the WHO Medical Product Alert referring to five different Oral liquid dosage forms (syrup and suspension) detected in the Maldives and Pakistan. Some of the affected products have also been detected in Belize, Fiji and […]
Press Briefing On Reported Decline In Pharmaceutical Imports Into Nigeria
The attention of the Management of the National Agency for Food and Drug Administration and Control (NAFDAC) has been drawn to publications in online tabloid, specifically the Business Day edition of 24th August 2023 titled “Nigeria’s Pharmaceutical Import drop 63% in Two Years”. While the write up quoted this data from the International Trade Center, a […]
Illegal Importation, Sales and Distribution of Crusader Soaps Containing Mercury in Nigeria
Protocols: It is my pleasure to welcome you all to this Press briefing. In the course of its regulatory activities, the investigation and enforcement (I&E) Directorate of NAFDAC has discovered a syndicate that specializes in importing banned Crusader soaps containing Mercury. The syndicate uses forged customs documents to import the product into the country. Further […]
Press Briefing: Re-NAFFDAC approves GLUCOZIL, AAU’s herbal medicine for diabetes
The Agency’s attention has been drawn to a publication on August 24th, 2023, circulating in many print and online media which claims that a Listed Local Herbal Medicine “Glucozil” produced by Ambrose Alli University Ekpoma was approved by NAFDAC for the treatment and cure of Diabetes Mellitus and capable of treating Benign prostatic hyperplasia (Prostrate […]
Important Covid-19 Vaccine Safety Communication To Healthcare Providers
, Important Covid-19 Vaccine Safety Communication To Healthcare Providers KEY POINTS Possible Rare Event, Severe Allergic Reactions (Anaphylaxis) and Thromboembolic Events with Some Covid-19 Vaccines (probably due to underlying medical conditions and use of certain medications). Possible contraindications with Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), especially Diclofenac with COVID-19 Vaccines NAFDAC maintains that authorised vaccines should continue […]
